Mercer InternationalBioceres

Mercer International vs Bioceres

상장 기업 vs 작물 형질을 개발하는 라틴아메리카 농업 생명공학 기업. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.

Mercer International pulps wood into market pulp and produces lumber from British Columbia and Germany, with revenues that move sharply with global fiber and building material demand, while Bioceres C...

투자 분석

장점

  • Mercer International operates globally in the forest products sector, providing geographic diversification with operations in Germany, the U.S., and Canada.
  • The company has a robust revenue base of approximately $1.95 billion on a trailing twelve months basis, indicating significant scale.
  • Mercer has a strong institutional ownership at over 75%, suggesting confidence from large investors.

고려 사항

  • Recent financial results show significant underperformance, including a Q3 2025 revenue shortfall of $49.4 million and an operating EBITDA turning negative to -$28.1 million.
  • The company faces persistent headwinds, including weak pulp pricing, intensified pulp substitution trends, and macroeconomic uncertainty impacting demand.
  • High leverage is indicated by a debt-to-equity ratio exceeding 330%, which increases financial risk amid deteriorating earnings and negative profit margins.

장점

  • Bioceres Crop Solutions provides diversified agricultural input products spanning seeds, crop protection, and crop nutrition with proprietary biotechnological innovations like drought-tolerant seed technology HB4.
  • The company maintains a presence on NASDAQ with a market capitalization around $297 million, supporting liquidity and visibility.
  • Bioceres shows historical enterprise value stability averaging around $518 million over the last decade, indicating sustained market valuation despite recent fluctuations.

고려 사항

  • Enterprise value has declined by over 33% compared to recent quarterly averages, reflecting investor concerns or market volatility affecting the stock.
  • The agricultural inputs industry is exposed to commodity price volatility, regulatory changes, and climatic risks that can impact Bioceres’ operational performance and revenue growth.
  • Bioceres’ relatively modest market capitalization and enterprise value compared to larger peers may limit its competitive scale and financial flexibility in aggressive market expansions.

Nemo에서 MERC 또는 BIOX 매수하기

Nemo Logo Fade
🆓

수수료 무료

주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.

🔒

신뢰할 수 있는 규제 기관 인가

2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.

💰

현금 예치금 6% 이자

투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.

자주 묻는 질문